Search peptides, terms, sources/
Research source · 2026

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
179 US adults with obesity or overweight, without type 2 diabetes
Sample size
179
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Phase 2; sponsor-funded (Eli Lilly). The primary endpoint was at 32 weeks. Abstract read via Europe PMC; full text not read.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.